Your browser doesn't support javascript.
loading
Safety and efficacy of osimertinib rechallenge or continuation after pneumonitis: A multicentre retrospective cohort study.
Imaji, Mihoko; Fujimoto, Daichi; Sato, Yuki; Sakata, Yoshihiko; Oya, Yuko; Tamiya, Motohiro; Suzuki, Hidekazu; Ikeda, Hideki; Kijima, Takashi; Matsumoto, Hirotaka; Kanazu, Masaki; Hino, Aoi; Inaba, Megumi; Tsukita, Yoko; Arai, Daisuke; Maruyama, Hirotaka; Hara, Satoshi; Tsumura, Shinsuke; Kobe, Hiroshi; Sumikawa, Hiromitsu; Sakata, Shinya; Yamamoto, Nobuyuki.
Affiliation
  • Imaji M; Internal Medicine III, Wakayama Medical University, Wakayama 641-8509, Japan.
  • Fujimoto D; Internal Medicine III, Wakayama Medical University, Wakayama 641-8509, Japan. Electronic address: daichi@wakayama-med.ac.jp.
  • Sato Y; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Hyogo, Japan.
  • Sakata Y; Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, Kumamoto, Japan.
  • Oya Y; Department of Thoracic Oncology, Aichi Cancer Center Hospital, Aichi, Japan.
  • Tamiya M; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Suzuki H; Department of Thoracic Oncology, Osaka Habikino Medical Center, Osaka, Japan.
  • Ikeda H; Department of Respiratory Medicine, Kimitsu Chuo Hospital, Chiba, Japan; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Kijima T; Department of Respiratory Medicine and Hematology, Hyogo Medical University, Hyogo, Japan.
  • Matsumoto H; Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan.
  • Kanazu M; Department of Thoracic Oncology, National Hospital Organization Osaka Toneyama Medical Center, Osaka, Japan.
  • Hino A; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Inaba M; Division of Respiratory Medicine, Kumamoto Chuo Hospital, Kumamoto, Japan.
  • Tsukita Y; Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Arai D; Department of Internal Medicine, Saiseikai Utsunomiya Hospital, Tochigi, Japan.
  • Maruyama H; Department of Respiratory Medicine, Japan Organization of Occupational Health and Safety, Kumamoto Rosai Hospital, Kumamoto, Japan.
  • Hara S; Department of Respiratory Medicine, Itami City Hospital, Hyogo, Japan.
  • Tsumura S; Department of Respiratory Medicine, Kumamoto Regional Medical Center, Kumamoto, Japan.
  • Kobe H; Department of Respiratory Medicine, Kurashiki Central Hospital, Okayama, Japan.
  • Sumikawa H; Department of Radiology, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.
  • Sakata S; Department of Respiratory Medicine, Kumamoto University Hospital, Kumamoto, Japan.
  • Yamamoto N; Internal Medicine III, Wakayama Medical University, Wakayama 641-8509, Japan.
Eur J Cancer ; 179: 15-24, 2023 01.
Article in En | MEDLINE | ID: mdl-36470023

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Cancer Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Cancer Year: 2023 Document type: Article Affiliation country: Country of publication: